Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience.
Emanuele D'AmicoF PattiA ZanghìS Lo FermoC G ChisariM ZappiaPublished in: Expert review of clinical pharmacology (2018)
lateral switch to IFN beta-1a 44 mcg and escalation switch to fingolimod showed same ability in influencing RRMS disease activity at 24 months.